Management of chronic pain in children

Archives of Disease in Childhood: Education and Practice Edition

Volumn 91, Issue 4, 2006, Pages

  Currie, John M ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANANDAMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; MELATONIN; N METHYL DEXTRO ASPARTIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ACUPUNCTURE; ANALGESIA; AROMATHERAPY; BEHAVIOR THERAPY; CHRONIC PAIN; CLINICAL FEATURE; COGNITIVE THERAPY; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DRUG POTENTIATION; ELECTROANALGESIA; EPIDURAL ANESTHESIA; HEALTH PROGRAM; HUMAN; INTRACTABLE PAIN; MEDICAL ASSESSMENT; MEDICAL ETHICS; MEDICAL PRACTICE; NEUROPATHIC PAIN; PHYSIOTHERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT PLANNING; VISCERAL PAIN;

EID: 33845238459     PISSN: 17430585     EISSN: None     Source Type: Journal    
DOI: 10.1136/adc.2005.071605     Document Type: Review

References (28)

1. Southall DP, Burr S, Smith RD, et al. The Child-Friendly Healthcare Initiative (CFHI): healthcare provision in accordance with the UN Convention on the Rights of the Child. Pediatrics 2000;106:1054-64.
2. Anon. http://www.childfriendlyhealthcare.org/publications/pediatrics.htm.
3. Bonica JJ. Evolution and current status of pain programs. Journal of Pain & Symptom Management 1990;5:368-74.
4. Taddio A, Katz J. The effects of early pain experience in neonates on pain responses in infancy and childhood. Paediatric Drugs 2005;7:245-57.
5. Bonica JJ. The management of pain, volume 1, 2nd ed. Lea and Febiger: Pennsylvania, 1990.
6. Franck LS, Greenberg CS, Stevens B. Pain assessment in infants and children. Pediatr Clin N Am 2000;47:487-512.
7. Fitzgerald M, Howard RF. The neurobiologic basis of pediatric pain. In: Schecter NL, Berde CB, Yaster M, eds. Pain in infants, children and adolescents, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2003:19-42.
8. Hu P, McLachlan EM. Long-term changes in the distribution of galanin in dorsal root ganglia after sciatic or spinal nerve transection in rats. Neuroscience 2001;103:1059-71.
9. Bago M, Dean C. Sympathoinhibition from ventrolateral periaqueductal gray mediated by 5-HT(1A) receptors in the RVLM. Am J Physiol Regul Integr Comp Physiol 2001;280:R976-84.
10. Holmberg K, Shi TJ, Albers KM, et al. Effect of peripheral nerve lesion and lumbar sympathectomy on peptide regulation in dorsal root ganglia in the NGF-overexpressing mouse. Exp Neurol 2001;167:290-303.
11. Scislo TJ, Kitchen AM, Augustyniak RA, et al. Differential patterns of sympathetic responses to selective stimulation of nucleus tractus solitarius purinergic receptor subtypes. Clin Exp Pharmacol Physiol 2001;28(1-2):120-4.
12. Chabal C. Membrane stabilizing agents and experimental neuromas. In: Fields HL, Liebeskind JC, eds. Pharmacological approaches to the treatment of chronic pain: new concepts and critical issues. Progress in pain research and management. Seattle: IASP Press, 1994;1:205-210.
13. Halligan PW. Zeman A. Berger A. Phantoms in the brain. Question the assumption that the adult brain is "hard wired". BMJ 1999;319:587-8.
14. Anon. http://www.bris.ac.uk/Depts/Synaptic/info/glutamate.html.
15. Dev KK, Henley JM. The regulation of AMPA receptor-binding sites. Molecular Neurobiology 1998;17(1-3):33-58.
16. McCleane G. Pharmacological strategies in relieving neuropathic pain. Expert Opinion on Pharmacotherapy 2004;5:1299-312.
17. Manning DC. New and emerging pharmacological targets for neuropathic pain. Current Pain & Headache Reports 2004;8:192-8.
18. Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989;39:129-44.
19. Schurmann M, Gradl G, Wizgal I, et al. Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I. Clin J Pain 2001;17:94-100.
20. Cleary AG, Sills JA, Davidson JE, et al. Reflex sympathetic dystrophy. Rheumatology (Oxford) 2001;40:590-1.
21. Janig W, Baron R. Complex regional pain syndrome: mystery explained. Lancet Neurology 2003;2:687-97.
22. Ceballos A, Cabezudo L, Bovaira M, et al. Spinal cord stimulation: a possible therapeutic alternative for chronic mesenteric ischaemia. Pain 2000;87:99-101.
23. Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci 2004;101:9861-6.
24. Kemler MA, Rijks CP, De Vet HC. Which patients with chronic reflex sympathetic dystrophy are most likely to benefit from physical therapy? J Manipulative Physiol Ther 2001;24:272-8.
25. Maihofner C, Handwerker HO, Neundorfer B, et al. Patterns of cortical reorganisation in complex regional pain syndrome. Neurology 2003;61:1707-15.
26. Buskila D, Neumann L, Press J. Genetic factors in neuromuscular pain. CNS Spectrums 2005;10:281-4.
27. Finegold AA, Mannes AJ, Iadarola MJ. A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Human Gene Therapy 1999;10:1251-7.
28. Smith O. Pain-killer genes. Science 1999;284:1634.